Find clinical trials for Lung Cancer in New York, NY
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lung Cancer trials near New York, NY, USA:
This is a prospective study providing lung cancer subjects at R.J. Zuckerberg Cancer Center with a customized exercise pro ...
New Hyde Park, New York, United States
of standard devices in a novel configuration, which may benefit lung cancer patients by reducing the radiation dose to critical str...
Phase 2
New York, New York, United States
with a type of radiation therapy called stereotactic body radiation (SBRT) is a more effective treatment for early-stage non-small cell lung ...
Phase 2
New York, New York, United States and 8 other locations
The purpose of this study is to find out how many people with HER2-amplified or HER2-mutated non-small cell lung cancer (NSCLC) exp....
Phase 2
New York, New York, United States and 9 other locations
This is a phase I clinical trial to determine the maximum tolerated dose (MTD) of KK-LC-1 TCR-T cells for the treatment of metastatic cancers...
Phase 1
New Brunswick, New Jersey, United States and 1 other location
chemotherapy (carboplatin and pemetrexed) in people with metastatic lung cancer that has a change (mutation) in the gene EGFR. Osim ...
Phase 2
New York, New York, United States and 17 other locations
a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non-small-cell lung...
Phase 2
New York, New York, United States and 90 other locations
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
combination) vs durvalumab in limited-stage (LS)-small-cell lung cancer (SCLC) participants.The main goals of this study are to:* E...
Phase 2
White Plains, New York, United States and 32 other locations
Chimeric Degradation Activation Compound (CDAC). BG-60366 is designed to degrade mutant EGFR, which is a common cause for Non-Small Cell Lung...
Phase 1
New York, New York, United States and 28 other locations
Eligible untreated participants with Extensive Stage Small Cell Lung Cancer (ES-SCLC) who are ≥ 18 years of age will be randomized ...
Phase 2
The Bronx, New York, United States and 4 other locations
Clinical trials
Research sites
Resources
Legal